Cargando…
Increased ABCC2 expression predicts cisplatin resistance in non‐small cell lung cancer
Long‐term use of platinum‐based drugs can cause non‐small cell lung cancer (NSCLC) to develop extremely strong drug resistance. Increasing the drug dosage does not have better treatment effects and could lead to serious complications. High levels of drug resistance are considered to be characteristi...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983913/ https://www.ncbi.nlm.nih.gov/pubmed/32815556 http://dx.doi.org/10.1002/cbf.3577 |